IDEAYA to Participate in Upcoming September 2020 Investor Relations Events

On August 31, 2020 IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, reported that management will present at the following upcoming investor relations events (Press release, Ideaya Biosciences, AUG 31, 2020, View Source [SID1234564206]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

JP Morgan CEO Series
Fireside Chat hosted by Analyst Anupam Rama
Tuesday, September 8, 2020 at 12:00pm ET
Citi 15th Annual BioPharma Conference
Company Panel: Precision Targeted Drugs in Oncology hosted by Analyst Mohit Bansal
Wednesday, September 9th at 11:40am ET
RW Baird Global Health Care Conference
Fireside Chat hosted by Analyst Madhu Kumar
Thursday, September 10th at 3:45pm ET
H.C. Wainwright 22nd Annual Global Investment Conference
Company Presentation
Monday, September 14th at 11:30am ET
Cantor Fitzgerald Global Healthcare Conference
Company Presentation
Thursday, September 17th at 4:40pm ET
A live audio webcast of each presentation will be available by visiting the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at View Source A replay of the webcasts will be available for 30 days following the live event.